Weight gain from medication: which drugs can change your weight and what you can do
Some medications can change your appetite, insulin, energy expenditure or water balance. Here you will find out which drug groups may be behind this, what studies show and which questions you can take to your next doctor's appointment.
A medication that gives you stability is not a mistake. A few extra kilos are not a character flaw. Both deserve an open conversation, not a guilty conscience.
Imagine you are prescribed a new medication. After a few weeks, you finally feel better. You are sleeping again. You laugh more often again. Everyday life feels lighter.
And then, after three months, you stand in front of the mirror one morning. Your favourite trousers suddenly won't do up. You haven't eaten more than usual, or at least that's what you think. A question comes up in your mind that feels almost forbidden: is it the medication?
I know this pattern very well. And I want to be honest right away: a scene like this cannot prove that the medication is the cause. Weight has many dials, from sleep and stress to movement. But the question is a fair one, and it deserves a good answer.
Perhaps you've landed right here because you recognise yourself in this scene. Then you are in good company. Weight gain from medication is a topic that often gets little time in a busy practice day. Yet knowing how things connect can take a lot of pressure off your mind.
In this article, I sort the most important drug groups by their mechanism. In other words, by the point at which they may step into your metabolism: appetite, insulin action, energy expenditure or water balance. If you'd like to understand more generally why the scales sometimes don't do what they should, also read Why am I not losing weight? and Insulin resistance and belly fat.
One thing up front, and it matters to me: this text is not a call to stop taking anything. Any change to a medication belongs in a conversation together with your treating doctor. What you get here is knowledge and good questions for exactly that conversation.
Yes, some medications can change your weight. A large meta-analysis of 257 studies found, depending on the drug, an average of around 0.3 to 2.8 kilograms more.1 Other drugs were more often associated with weight loss. The routes differ: more appetite, more storage via insulin, a slightly reduced energy expenditure or water retention. You should never stop or switch a medication on your own, only together with your doctor.
Key points at a glance
- Medications can change your weight via four routes: appetite, insulin, energy expenditure and water. The route determines which countermeasure may fit.
- Within antidepressants and antipsychotics, there are large differences. Mirtazapine, paroxetine, amitriptyline, olanzapine and clozapine stand out more often, other drugs hardly at all.
- Insulin, sulfonylureas and glitazones can increase weight. At the same time, well-controlled blood sugar levels can help protect against long-term damage to the eyes, kidneys and nerves.
- For the pill and the patch, Cochrane reviews show no proven causal link with weight gain. For the three-month injection, some studies point to more gain.
- Never stop on your own. Measure your weight and waist early, and take specific questions to your doctor's appointment.
How can medications change your weight?
Via four routes: they can increase appetite, promote storage via insulin, slightly reduce energy expenditure or hold water in the tissue. Often several routes interlock.1
Perhaps you're wondering: how can a small tablet change so much? You swallow it in the morning, and it's meant to influence your mood, your pain or your blood pressure. Not your trouser size.
But your weight is not a single dial. It's more like a household with four departments. A medication only needs to step into one of them, and the balance can shift. This usually doesn't happen overnight, but quietly, over weeks and months.
Appetite: the satiety brake
In the hypothalamus, your appetite control centre, there are receptors that work like brake pedals. These include the histamine H1 receptor and the serotonin 5-HT2C receptor. If a drug blocks these pedals, the feeling of fullness may come later and hunger may grow louder.
Insulin: the warehouse manager
Insulin moves sugar out of the blood into your stores. More insulin means sugar goes into storage instead of being lost through the urine. That is intended and can help protect your blood vessels, but it can also add kilos.
Energy expenditure: the turned-down furnace
Some drugs turn the furnace down a little. The heart beats more calmly, heat production after meals drops, and perhaps you move a little less. Small differences can add up over months.
Water: the sponge
Your tissue can soak up water like a sponge. The scales then show more, even though not a single gram of fat has been added. Swollen ankles or rings that feel tighter are typical signs.
At the cellular level, you can picture this as a key that gets stuck in the wrong lock. The drug occupies a receptor, and the signal "full" only arrives in a muffled form. Or it changes how sensitively your muscle and fat cells respond to insulin. That is the metabolic lens, and it helps explain why two people on the same tablet can react so differently.
A team led by Domecq at the Mayo Clinic in Rochester analysed 257 randomised trials involving a total of 84,696 people. They observed that olanzapine, gabapentin, pioglitazone and sulfonylureas, for example, were associated with more weight, while metformin, topiramate or bupropion were associated with less. For you, this means: weight is a known property of many drugs, and within a group there are often options with a different profile.1
Domecq JP et al. J Clin Endocrinol Metab 2015 · DOI: 10.1210/jc.2014-3421The Endocrine Society guideline therefore advises taking weight into account when choosing a medication and, where it makes medical sense, preferring weight-neutral options.2 This is not a criticism of any single drug. It is an invitation to add one more line to the list when weighing things up.
What you can take away from this: pay attention to how the gain feels. More hunger points more towards the appetite axis, swollen ankles more towards water. This observation is worth its weight in gold for your next doctor's appointment.
Weight here is a side effect, not a failure. If a drug loosens your satiety brake or drives your warehouse manager, it has nothing to do with a lack of discipline.
It is biology. And biology can be talked about, monitored and supported.
And now you know why the same number on the scales can have very different causes, and why it is worth taking a close look.
Antidepressants, antipsychotics, antihistamines: when appetite grows louder
Some drugs from these groups can loosen the satiety brake in the brain. In studies, mirtazapine, paroxetine and amitriptyline as well as olanzapine and clozapine stand out in particular.35 Other drugs from the same groups behave largely neutrally.
Do you know that feeling of going back to the fridge after dinner, even though you are actually full? Some people describe exactly this after starting a new medication. Not a craving out of boredom, but a hunger that feels physical.
This hunger is not a character trait. It can be a signal from your hypothalamus, whose brake pedals are currently half blocked. How strongly this happens depends on the individual drug, and on how your body is built.
A large meta-analysis from Bologna with 116 studies paints a clear picture. Amitriptyline, mirtazapine and paroxetine were associated with a higher risk of weight gain. Fluoxetine in the acute phase and bupropion tended to show slight losses.3 The differences between individuals were large, and they showed up mainly in long-term treatment.
A team led by Gafoor at King's College London followed the health records of 294,719 adults over ten years. Per 100 people per year, 11.2 gained at least five percent on antidepressants, compared with 8.1 without antidepressants, and the risk remained elevated for at least six years. For you, this means: the risk is measurable but by no means affects everyone, and an observation like this is not proof of cause and effect.4
Gafoor R et al. BMJ 2018 · DOI: 10.1136/bmj.k1951Another way to read this figure: in the second year of treatment, there was, statistically, one additional marked gain for roughly every 27 people treated.4 That is relevant. But it also means that the vast majority do not gain weight because of it.
A team led by Pillinger at King's College London analysed 100 randomised trials involving 25,952 people with schizophrenia on 18 antipsychotics. After only around six weeks, the range stretched from 0.23 kilograms less on haloperidol to 3.01 kilograms more on clozapine, with olanzapine also near the top. For you, this means: within this group there are options that are gentler on the metabolism, such as aripiprazole, lurasidone or ziprasidone, and the choice should suit you.5
Pillinger T et al. Lancet Psychiatry 2020 · DOI: 10.1016/S2215-0366(19)30416-XA meta-analysis from Maastricht with 307 studies adds to the picture. Almost all antipsychotics were associated with weight gain over longer use, and only with amisulpride, aripiprazole and ziprasidone was the gain small. People receiving an antipsychotic for the first time gained more. And switching drugs did not, on average, lead to weight loss.6 So a switch is not a magic button, but a weighing-up that belongs in medical hands.
Why these drugs in particular? This is where a receptor comes into play that you may know from hay fever: the histamine H1 receptor. In the brain, histamine is not just an allergy messenger, but also a wake-up signal and a satiety signal.
A team led by Kroeze at Case Western Reserve University measured in the lab how strongly 17 antipsychotics bind to various receptors. Binding to the H1 receptor predicted short-term weight gain best and correctly classified 15 of 17 drugs. For you, this means: the histamine brake is a plausible explanation, measured on receptors in the lab and matched against weight data from studies.7
Kroeze WK et al. Neuropsychopharmacology 2003 · DOI: 10.1038/sj.npp.1300027This fits with an analysis of the large US health survey NHANES at Yale University. People who took prescription H1 antihistamines weighed more on average, had a larger waist circumference and higher insulin levels.8 Whether the medication was the cause is something a snapshot like this cannot show. In Domecq's large meta-analysis, the data on antihistamines were too thin for a clear verdict.1
A team led by Davey at University College Cork gave rats olanzapine and examined their gut flora. Olanzapine changed the composition of the gut bacteria, and when the animals also received antibiotics, weight gain, fat storage and inflammatory cells in the fatty tissue were lower. For you, this means: the gut could play a part, which is biologically plausible but not yet proven in humans, and certainly no reason to take antibiotics.9
Davey KJ et al. Transl Psychiatry 2013 · DOI: 10.1038/tp.2013.83Nervous system
Blocked H1 and 5-HT2C receptors can dampen the satiety signals in the hypothalamus. On top of that comes tiredness: when you are sedated, you often move less without noticing.
Immune system
In the animal study, more scavenger cells migrated into the fatty tissue on olanzapine. This points to a silent inflammation in the stores, which has not yet been proven in humans.
Metabolism
More appetite meets cells that may respond less well to insulin. More energy then ends up in storage, often around the belly.
Hormonal system
Satiety hormones such as leptin tell the brain how full the stores are. If reception in the hypothalamus is dampened, this message may arrive more quietly. This is a working model, not a measurement for every medication.
What you can take away from this: if your hunger grows noticeably louder after starting a new medication, write it down early. Bring it up at your next appointment instead of fighting the fridge for weeks. And if food is also a comfort for you right now, you might like to read Emotional eating.
Some of the kilos can be part of recovery. In the large network meta-analysis, a stronger improvement in symptoms went along with slightly more weight.5 When you sleep, feel and live again, you often eat with pleasure again too.
That does not mean you simply have to accept the kilos. It means: you can be proud of your stability and still take good care of your metabolism.
And now you know why it is not "the antidepressant" as such that makes you gain weight, and why it depends on the individual drug and on you.
Antiepileptics, lithium and nerve pain medication: between insulin, tiredness and water
Valproate, gabapentin and pregabalin can increase weight in some people.11012 In a more recent meta-analysis, lithium fares better than its reputation suggests.11 Topiramate and zonisamide were even associated with less weight in studies.1
Perhaps you take a medication that prevents seizures, keeps your mood stable or dampens nerve pain. Finally calmer nights, finally an everyday life without fear of the next crash. And then, after a few weeks, the scales show a number that unsettles you.
You probably don't take these medications casually. They often protect something very valuable. That makes a calm look at what studies show all the more important.
Let's start with valproate, a long-established drug for epilepsy and bipolar disorder. A team led by Verrotti in Chieti summarised the evidence on valproate and weight. The gain usually showed up in the first three months, and women might be more susceptible.10 Insulin resistance is among the mechanisms being discussed, but the exact process is still debated.
Do you remember insulin, the warehouse manager? With insulin resistance, the cells hear its knocking less well, so it has to knock louder. And as long as a lot of insulin is circulating in the blood, the fat stores tend to stay locked.
The team led by Verrotti advises doctors to weigh patients before the start. If around two kilograms are added after the first month, they recommend thinking about alternatives.10 This weighing-up belongs in medical hands, because with epilepsy an ill-considered switch can make seizures more likely.
A team led by Gomes-da-Costa in Barcelona summarised studies on lithium and weight in bipolar disorder. On average, just under half a kilogram was added, statistically no different from placebo and less than with active comparator drugs. For you, this means: when it comes to weight, lithium is better than its reputation, even though some individuals may still gain weight.11
Gomes-da-Costa S et al. Neurosci Biobehav Rev 2022 · DOI: 10.1016/j.neubiorev.2021.07.011Lithium can also make you thirsty. Clinically, I observe that this thirst is sometimes quenched with juice or soft drinks. That can then show up on the scales. Ask at your appointment what is best for you to drink. With lithium, water balance plays a special role.
Pregabalin and gabapentin are used for nerve pain, epilepsy and sometimes anxiety. In the Mayo analysis, gabapentin was associated with an average of 2.2 kilograms more in the studies.1 For pregabalin, there is a particularly revealing analysis over time.
A team led by Cabrera at Rutgers University jointly analysed the weight data of 3,187 people from 41 pregabalin studies. A good four out of five stayed close to their starting weight, and about one in six gained at least seven percent, mostly only after months. For you, this means: weight gain is not inevitable, but it can come late, so stay attentive even after months.12
Cabrera J et al. Curr Med Res Opin 2012 · DOI: 10.1185/03007995.2012.684044Another striking finding: those who gained weight tended to weigh less at the start on average.12 Two meta-analyses of randomised trials from Florence and Oxford also list water retention on pregabalin, especially in the legs.1314 The Oxford analysis of 28 studies with 6,087 people also lists weight gain, dizziness and drowsiness.14
So some of the kilos may be water that collects in the tissue as if in a sponge. If you press your thumb on your shin for a few seconds and a dent remains, that is a sign of it. Swelling like this should be checked by a doctor promptly, because it can also have other causes.
At the cellular level, several threads come together here. Pregabalin and gabapentin bind to a docking site on the calcium channels in nerve cells. They turn down signal transmission, like a dimmer on a lamp that is too bright. The same dampening can make you tired, and when you are tired, you often move less without noticing. That is the nervous system lens. With valproate, the metabolic lens tends to be in the foreground.
The Mayo analysis shows once again how different drugs within one group can be: topiramate and zonisamide were even associated with less weight there.1 This is not a recommendation to switch, because every drug brings its own side effects. But it shows that there may be room for manoeuvre, which you can explore together with your doctor.
Please never stop antiepileptics on your own and do not reduce them by yourself. That can make seizures more likely, even after a long seizure-free period. For your everyday life, this means: weigh yourself when you start a new therapy and then weekly, in the morning at the same time. Note whether it is mainly your hunger that rises, your tiredness or the swelling around your ankles. These three clues can show your doctor which axis is the sticking point.
A calm nervous system is a great asset. In epilepsy or bipolar disorder, the medication often helps protect against seizures and crises. These can restrict your life far more than a few kilos.
So the question is not "medication or weight?". It is: how does your nervous system stay protected, and how can your metabolism still keep up well?
And now you know why, with antiepileptics, lithium and nerve pain medication, it is not only appetite that counts, but also insulin, tiredness and water.
Insulin, sulfonylureas, glitazones: when sugar is allowed back into storage
Insulin, sulfonylureas and glitazones can increase weight by a few kilograms.1516 One reason: sugar that was previously lost in the urine stays in the body and is stored.17 At the same time, good blood sugar control can lower the risk of long-term damage, which is why both sides belong on the scales.15
Your blood sugar is finally in the target range. The constant thirst is gone, and you feel more awake. And yet the scales show a few more kilos. That can feel like a punishment for something you did right.
I understand this frustration well. And I'd like to show you why your body isn't working against you here, but is doing something very logical.
Imagine high blood sugar as an overflowing bathtub. Above a certain level, the kidneys channel sugar into the urine, and energy along with it. When a therapy lowers the level, this energy stays in the body and ends up in storage.17
A review from the Royal Surrey County Hospital in Guildford names further reasons.17 Some people eat a little more as a precaution, out of fear of low blood sugar. The specialist literature calls this defensive eating. Injected insulin also doesn't quite follow the fine rhythm of a healthy pancreas. And worry about the kilos can lead to a necessary insulin therapy being delayed.
At the cellular level, insulin is a building signal. It opens the doors of muscle and fat cells to sugar and slows the breakdown of fat in the fat cells. Sulfonylureas press the insulin button directly in the pancreas, even when there is little sugar around. Your blood sugar can then drop too low, and your body signals hunger.
A team from the UKPDS study group in the United Kingdom followed 3,867 people with newly diagnosed type 2 diabetes for around ten years. With intensive therapy, an average of 2.9 kilograms more was added, and the risk of damage to small blood vessels fell by a quarter. For you, this means: the kilos are a known price, set against a clear protective benefit for the eyes and kidneys.15
UK Prospective Diabetes Study Group. Lancet 1998 · DOI: 10.1016/S0140-6736(98)07019-6There were also differences within the study. On insulin, an average of 4.0 kilograms was added, on chlorpropamide 2.6 and on glibenclamide 1.7.15 In the Mayo analysis, sulfonylureas came in at around 1.8 to 2.8 kilograms more, depending on the drug. Metformin, by contrast, was associated with slightly less weight there.1
A team led by Phung at the University of Connecticut analysed 27 trials in which a second drug was added to metformin. All of them lowered long-term blood sugar to a similar degree, but glitazones, sulfonylureas and glinides brought around two kilograms more, while other groups did not. For you, this means: when it comes to blood sugar, many options are close together, but when it comes to weight, they can differ markedly.16
Phung OJ et al. JAMA 2010 · DOI: 10.1001/jama.2010.405GLP-1 analogues, alpha-glucosidase inhibitors and DPP-4 inhibitors were weight-neutral there or were associated with slightly less weight.16 The so-called weight-loss injection also belongs to the GLP-1 analogues. You can read what it can and cannot do in Weight-loss injection: what it can do.
Glitazones such as pioglitazone make cells more sensitive to insulin. In the Mayo analysis, pioglitazone was associated with 2.6 kilograms more.1 Part of this may be water. The American heart and diabetes associations have issued a joint statement on this.18 Water retention can put additional strain on a weakened heart, which is why swollen ankles on glitazones should be checked by a doctor quickly.
Please never leave out insulin or other diabetes medication on your own, and do not change the dose by yourself. Blood sugar that is too high and blood sugar that is too low can both become dangerous. What you can do: if you eat as a precaution out of fear of low blood sugar, talk about it openly. Sometimes treatment can be adjusted so that you don't have to eat against your blood sugar.
Your muscles are the largest sugar store in your body. Exercise and nutrition can improve your sensitivity to insulin.17 You can read how strength training plays a part in this in Strength training for diabetes and insulin resistance. Also ask whether a drug with a different weight profile might be an option for you.
The kilos on insulin are often the trace of a body that holds on to energy again instead of losing it. That doesn't make them unimportant.
But it makes them a task that can be tackled together. They are not a sign that you are doing something wrong.
And now you know why better blood sugar levels and a few more kilos are not a contradiction, but belong in the same conversation.
Beta blockers: when the furnace burns a little lower
Some beta blockers can add a little weight in the first months, a median of 1.2 kilograms in one systematic analysis.19 After that, nothing more was added there. In a large comparative study, carvedilol showed markedly less gain than metoprolol tartrate.20
Your heart beats more calmly, and your blood pressure is finally right. But the stairs up to the third floor feel heavier than they used to. In the evening, you get tired more quickly. And the scales show a kilo more, even though you are not eating any differently.
Perhaps you are wondering whether it is the new medication. That is a fair question, and it deserves an honest answer.
Imagine your metabolism as a furnace. Adrenaline and noradrenaline are the bellows that blow air into the fire. They dock at sites called beta receptors. A beta blocker occupies some of these docking sites. Your heart beats more calmly, and the furnace may burn a little lower.
A team led by Sharma at the Franz Volhard Clinic of the Charité in Berlin systematically analysed eight randomised trials.19 On beta blockers, weight was a median of 1.2 kilograms higher. The range stretched from 0.4 kilograms less to 3.5 kilograms more. The gain showed up in the first months, and after that, nothing more was added.
For blood pressure medication as a whole, the large Mayo analysis found no clear change in weight, although the data there were thin.1 So it is worth taking a closer look at which drug is meant.
A team led by Messerli in New York followed 1,106 people with type 2 diabetes and high blood pressure for five months. On metoprolol tartrate, an average of 1.19 kilograms was added, on carvedilol only 0.17 kilograms, which statistically meant no increase. For you, this means: one beta blocker is not the same as another, and when it comes to weight, the individual drug can matter.20
Messerli FH et al. Am J Med 2007 · DOI: 10.1016/j.amjmed.2006.10.017I find one detail from this study fascinating. The weight gain there was not linked to long-term blood sugar, insulin resistance or blood pressure.20 So the kilos did not simply run in parallel with worse blood sugar values.
Mechanistically plausible, human studies still thin: A team led by Lee in Sydney gathered clues as to how beta blockers might turn down the furnace.21 In one series of measurements, heat production after meals was 50 percent lower in people on beta blockers. Fat burning was 32 percent lower, and physical activity 30 percent lower. These are clues from observations, not proof of cause and effect.
At the cellular level, beta receptors sit not only on the heart, but also on fat cells. There, adrenaline gives the signal to release stored fat. If some of these docking sites are occupied, the fat cell probably opens its store a little more hesitantly. At the same time, the beta blocker dampens the drive of your nervous system. Some days then feel calmer, but also more sluggish.
In practical terms, there is quite a lot you can do without touching your medication. If you train by heart rate zones, bring this up at your appointment. On beta blockers, your pulse rises less, so the usual zones often don't fit. Go by your breathing instead: you can still talk, but you can no longer sing. You can read more about easy endurance training in Understanding Zone 2 training.
Also ask about the specific drug. Whether a different beta blocker is an option for you is something only your doctor can decide, with your heart, heart rhythm and blood pressure in mind. And please never stop a beta blocker suddenly. Your body has got used to the brake, and an abrupt stop can trigger a racing heart and blood pressure spikes. With heart disease, that can become dangerous.
Your metabolism is not broken. It is running with the gas turned down a little, because your heart is meant to be protected.
Muscles are like extra furnaces in the house. Every strength training session can bring back some of the missing warmth.
And now you know why a beta blocker can turn the furnace down a little, and why it is worth talking about the individual drug.
Cortisone: a fire extinguisher that also hits your metabolism
Cortisone as a tablet or infusion can increase appetite and cause water retention when taken for longer.2223 It can also shift fat towards the face and neck.24 With short treatments, weight apparently did not rise in studies.22 The data in this section relate to cortisone taken by mouth or given as an infusion, not to sprays or ointments.
Perhaps you were given cortisone after a flare-up of asthma or rheumatism. The inflammation eased, and you could finally breathe freely or move again. And then came a hunger that feels like a hole in your stomach. In the mirror, your face seems rounder to you.
This is not a lack of discipline. This is hormone biology.
Cortisone is a copy of your body's own stress hormone, cortisol. Imagine it as a fire extinguisher. It can dampen inflammation quickly and powerfully, and in this way help protect organs. But the foam does not only land on the fire, it also lands in your metabolism.
At the cellular level, cortisone enters the cell and docks onto a receiver inside it, the glucocorticoid receptor. Together, they turn down genes for inflammatory messengers. That is the immune lens, and it explains the benefit. But the same switch also tells the liver to produce more sugar. When sugar rises, insulin rises, and the warehouse manager starts putting things back into storage.
A team led by Berthon in Newcastle, Australia, analysed 21 studies on cortisone tablets, appetite and weight. In short treatments, energy intake rose slightly but weight apparently did not, while with long-term use a clinically meaningful gain was possible. For you, this means: a short course of cortisone does not automatically mean more kilos, but a long-term therapy deserves an attentive eye.22
Berthon BS et al. Nutr Res 2014 · DOI: 10.1016/j.nutres.2013.12.006With short courses, a higher energy expenditure might balance out the small extra intake from food, the team suggests. It also stresses how differently people respond depending on their metabolism and activity.22
On top of this comes a redistribution. Fat can collect preferentially in the face and neck, which specialists call a moon face and a buffalo hump.24
A team led by Fardet at the Hôpital Saint-Antoine in Paris followed 88 people from the start of a longer, high-dose cortisone therapy. After three months, 61 percent showed a redistribution of fat in the face or neck, and after twelve months, 69 percent. For you, this means: this change is common, it comes early, and it is not a sign that you are doing something wrong.24
Fardet L et al. J Am Acad Dermatol 2007 · DOI: 10.1016/j.jaad.2007.04.018In that study, women, people under 50, people with a higher starting weight and people with a high energy intake had a higher risk.24 That is an association, not proof. But it shows where you can start yourself.
A team led by Huscher at the German Rheumatism Research Centre in Berlin surveyed 1,066 people with rheumatoid arthritis in routine clinical care.23 As the dose increased, a round face, bruises and swollen legs became more common. Weight gain was reported more often above a certain daily dose. Sleep problems also increased with the dose. Poor sleep can further fuel your hunger the next day, more on this in Sleep and weight loss.
You can use a few signs to tell whether the kilos are more likely water or more likely fat.
More likely water
- Often comes quickly, within a few days
- Pressing a finger on your shin leaves a dent
- Rings and shoes feel tighter in the evening than in the morning
- Your weight fluctuates noticeably from day to day
More likely fat
- Comes slowly, over weeks and months
- Your waist circumference grows steadily
- Your face and neck become fuller
- Your appetite is noticeably bigger
This is a rough guide, not a diagnosis. Sudden swelling, shortness of breath or several kilos within a few days should be seen by a doctor promptly.
What you can contribute yourself: plan meals with plenty of protein and fibre, such as lentils, beans, eggs or yoghurt. They can keep you full for longer when the cortisone hunger comes knocking. Because cortisone can raise your blood sugar, it is worth keeping an eye on sweets and white flour. You can read how the order of foods on your plate can influence your blood sugar in Keeping blood sugar stable.
Move as much as your condition allows. Your muscles are your allies here, because over time cortisone can wear down muscle tissue. You can read how your body's own cortisol is linked to belly fat in Cortisol and belly fat.
And please never stop cortisone on your own after taking it for a longer time. During this time, your adrenal glands have scaled back their own production. They need time to start up again, which is why the dose is usually reduced step by step. An abrupt stop can become dangerous.
Cortisone may have given you back your breath, your mobility or the protection of an organ. The round face is not a flaw, but the visible trace of this protection.
Many of these changes can recede when the dose comes down again. Until then, you are allowed to be kind to your reflection.
And now you know why cortisone does not simply make you gain weight, but acts on appetite, sugar, water and fat distribution all at once.
The pill, the IUD, the three-month injection: what studies on contraception show
For the combined pill and the contraceptive patch, a large Cochrane review found no evidence that they cause weight gain.25 With progestin-only methods, the mean gain in most studies after six to twelve months was under two kilograms.26 The three-month injection stands out more clearly in some studies, especially in adolescents with a high starting weight.2627
You have started a new contraceptive. After a few weeks, your jeans feel tighter. And straight away there is that sentence you have heard so often: "The pill makes you fat."
Perhaps you are thinking about simply stopping your contraception. Your impression counts, and it is okay to take it seriously. At the same time, it is worth looking at the studies, because they paint a more nuanced picture than the sentence from your circle of friends.
This worry is widespread. According to a large review, it can lead women not to start a very reliable contraceptive at all, or to stop it early.25 If you stop contraception without a replacement, an unplanned pregnancy can be the result. That is why it is worth taking a close look before you change anything.
First, two terms. The combined pill contains an oestrogen and a progestin. Progestins are synthetic relatives of the corpus luteum hormone progesterone, like a copied key for the same lock. The mini pill, the hormonal IUD, the implant and the three-month injection work with a progestin only. The copper IUD works entirely without hormones.
There is a Cochrane review for each of the two groups. Reviews like these are considered particularly careful summaries. Imagine them as a referee who does not judge a single match, but reviews all the recordings of a season.
A team led by Gallo at Ohio State University analysed 49 randomised trials on combined contraceptives. The four trials with a placebo or an untreated comparison group found no evidence that the pill or the patch causes a change in weight. For you, this means: a large effect of the pill on weight did not show up, but a small one cannot be ruled out with certainty.25
Gallo et al. Cochrane Database Syst Rev 2014 · DOI: 10.1002/14651858.CD003987.pub5Different combined preparations also mostly did not differ much from one another in terms of weight. And where this was examined, the number of discontinuations because of weight did not differ between the groups.25 However, the authors stress: a final verdict needs more studies with a hormone-free comparison group.
Why is this comparison group so important? Many people gain a little weight over the years anyway, entirely without hormones. Without a comparison, every kilo is automatically blamed on the pill, even if it has nothing to do with it.
A team led by Lopez at FHI 360 in Durham analysed 22 studies involving 11,450 women on progestin-only methods. In most studies, the gain was under two kilograms, and it was mainly the three-month injection that stood out, in three studies. For you, this means: most progestin methods show little influence on weight, but the injection is worth a closer look.26
Lopez et al. Cochrane Database Syst Rev 2016 · DOI: 10.1002/14651858.CD008815.pub4In 15 of the 22 studies, the groups did not differ in weight by more than chance could explain.26 Two retrospective analyses from this review show how large the difference with the injection can be. In one, women using the three-month injection gained an average of 2.28 kilograms more in the first year than women with a copper IUD. After three years, the difference was 3.17 kilograms.26
In the other analysis, women using the injection gained 6.6 kilograms over ten years, and women with a copper IUD 4.9 kilograms.26 This also shows you: the group with the hormone-free copper IUD gained a considerable amount of weight as well. That is exactly why the comparison group is so valuable.
In adolescents, body fat percentage rose more on the injection in one study than without a hormonal method. At the same time, the share of fat-free mass fell, meaning everything except fat. Two further studies saw slightly more body fat with the hormonal IUD than without a hormonal method, one of them also with a progestin pill.26 However, the team led by Lopez rates the overall quality of these data as low. Many studies did not assign the groups at random, and many women dropped out early.26
The picture becomes particularly clear in adolescents with a high starting weight. A team led by Bonny in Cleveland followed 450 girls between 12 and 18 years of age over 18 months. Girls with obesity, meaning marked overweight, gained an average of 9.4 kilograms with the three-month injection. With the pill it was 0.2, and without hormonal contraception 3.1 kilograms.27
In girls without obesity, the injection, the pill and no hormones were close together at 4.0, 2.8 and 3.5 kilograms. And the longer the girls with obesity received the injection, the more their weight rose.27 This is an observational study: it shows an association, not proof of a cause. You came across a similar pattern with cortisone: there, too, a higher starting weight was associated with more changes in fat distribution.24
At the cellular level, progestins bind to the docking sites for progesterone, the receptors. Depending on the drug, the copied key also fits a little into a neighbouring lock. That might be the lock for male hormones, for example, or the one for cortisone. This is why the preparations differ in their side effects. The three-month injection also releases its active ingredient from a depot over three months. Unlike a pill, it cannot be taken back once it has been given. Whether these properties explain the differences in weight is a question the studies in this section do not answer.
My suggestion for you: weigh yourself before starting a new contraceptive and measure your waist. Repeat both after three and after six months, always at the same time of day. That way you have real numbers instead of a feeling when you talk to your gynaecologist.
If your weight was already an issue beforehand and the three-month injection is being considered, talk openly about what the studies show. Also ask which methods stood out less in the studies and what suits your everyday life. The team led by Lopez writes that good counselling about typical weight changes can reduce early discontinuation.26
When fat-free mass falls, you lose some of the extra furnaces mentioned in the section on beta blockers. Regular strength training can help protect these furnaces, quite independently of your contraception. And if PCOS, a common hormonal metabolic disorder, plays a part for you, you can find more in the article Losing weight with PCOS.
And please never stop a contraceptive without a seamless replacement. Discuss every switch with your gynaecologist so that you stay protected without any gap.
The pill is not automatically to blame when your jeans feel tighter. And the three-month injection is not automatically bad. It simply deserves a closer look, especially if your weight was already an issue beforehand. A contraceptive that suits your body and your life is a piece of self-determination.
And now you know why the pill does not show a large effect on weight, and why the three-month injection still deserves a conversation of its own.
What you can do without stopping on your own
Don't change anything about your medication on your own. Track your weight and waist from day one, bring specific questions to your doctor's appointment and strengthen your foundation of exercise, protein and sleep. In studies, support programmes ranging from nutritional counselling to behavioural therapy were able to markedly slow weight gain on antipsychotics.29 In most drug groups, there are alternatives that are considered weight-neutral or are even associated with weight loss.30
Perhaps you are at exactly this point right now. The medication is doing you good, and yet every look in the mirror annoys you. It is tempting to simply leave out the tablets. I can understand this impulse well. But right now, it is worth pausing for a moment.
Your body has got used to the medication. Imagine a prop holding up a beam. If you yank it out in one go, the whole framework starts to wobble. If it is replaced slowly and according to plan, the house stays stable.
A team led by Henssler at the University of Cologne and the Charité in Berlin analysed 79 studies involving 21,002 people on stopping antidepressants. After stopping an antidepressant, 31 percent reported at least one discontinuation symptom, compared with 17 percent after stopping a placebo. For you, this means: roughly one in six to seven people experiences symptoms that are due to the stopping itself.28
Henssler et al. Lancet Psychiatry 2024 · DOI: 10.1016/S2215-0366(24)00133-0Severe discontinuation symptoms were rare. They occurred in 2.8 percent, and in 0.6 percent after a placebo.28 The team itself writes that these figures are meant to inform without causing unnecessary alarm. Paroxetine, which you know from the section on appetite, was associated with more severe symptoms. That is why a switch is usually planned step by step.
Please never stop or switch on your own
- Antidepressants: discontinuation symptoms such as dizziness or inner restlessness are possible, and your mood can tip over again.
- Antiepileptics: an abrupt stop can trigger seizures.
- Insulin and other diabetes medication: your blood sugar can get out of control.
- Beta blockers: a racing heart and blood pressure spikes are possible.
- Cortisone: after taking it for a longer time, your adrenal glands need time to produce enough cortisol on their own again.
- Antipsychotics and lithium: the risk of a relapse can rise.
- Contraception: without a seamless replacement, you are not protected against pregnancy.
Many people walk into the consulting room with an uneasy feeling. It feels as if you were complaining about something that is doing you good. Yet weight belongs in this conversation as a matter of course. A team led by Wharton in Toronto writes explicitly that effects on weight should be considered before prescribing and throughout treatment.30 The guideline of the Endocrine Society, a large professional society for hormone medicine, advises choosing drugs with a favourable weight profile whenever possible.2
Is weight gain known to occur with this drug?
Ask how common it is, how large it can be and over what period it usually appears.
Through which pathway does it change my weight?
Appetite, insulin, energy expenditure or water: the mechanism determines which counter-strategy makes sense.
Is there an alternative with a more favourable weight profile?
Options like these exist for many drug groups. Whether one of them suits your condition is something you decide together.
Can the dose, timing or form be adjusted?
The form of administration can also make a difference, for example a spray instead of a tablet.30
Which values will we keep an eye on?
Weight, waist circumference, blood sugar and blood lipids together give a clearer picture than the scales alone.
At what change will we talk about it again?
An agreed threshold spares you the brooding and gives you both a clear reason to talk.
How would a switch work if we decide on one?
Ask for the process to be explained step by step, including what to do if you experience symptoms.
And what if the medication has to stay? Then you are still not powerless. A large analysis looked at exactly this question.
A team led by Caemmerer at the Nathan S. Kline Institute in New York State analysed 17 randomised trials involving 810 people on antipsychotics. With programmes ranging from nutritional counselling to behavioural therapy, weight was on average 3.12 kilograms below that of the comparison groups, and a gain of more than 7 percent occurred in 29.7 instead of 61.3 percent. For you, this means: even if the medication stays, good support can make a noticeable difference.29
Caemmerer et al. Schizophr Res 2012 · DOI: 10.1016/j.schres.2012.03.017Statistically, there was one fewer marked gain for every four participants. In follow-ups up to twelve months after the end of the programme, on average after 3.6 months, weight was still 3.48 kilograms lower.29 One limitation belongs here: the benefit for weight was significant only in outpatient studies, meaning in people who were not being treated as inpatients.
At the cellular level, it is easy to explain why exercise can be so valuable here. Working muscles open extra gates for sugar, even without the warehouse manager insulin. In this way, your body can catch part of the surplus that a medication creates through appetite or insulin. You can find more on this in the article Strength training for diabetes and insulin resistance.
Here is how you can go about it:
- Note your weight and waist circumference once a week, ideally in the morning and always under the same conditions.
- Write down what changes: appetite, cravings, tiredness or swelling in your ankles and fingers.
- Raise the topic early, not only after months, and take your notes with you.
- Ask about support, such as nutritional counselling, an exercise programme or behavioural therapy.
- Keep at it, even if the scales hesitate at first. Small habits add up over months.
Bringing up your weight is not ingratitude towards a medication that is doing you good. It is part of good treatment, just like blood pressure or blood values. You are allowed to want both: to feel better and to feel comfortable in your body.
| Statement | Classification |
|---|---|
| Many commonly prescribed medications can change your weight. | Meta-analysis of 257 randomised trials1 |
| Antipsychotics differ greatly. Olanzapine and clozapine are among the drugs with the largest gain. | Network meta-analysis of 100 randomised trials5 |
| Insulin and sulfonylureas are, on average, associated with weight gain. | Large RCT and meta-analysis1516 |
| The combined pill and the patch do not show a large effect on weight. | Cochrane review of 49 randomised trials, limited data25 |
| The three-month injection can have a greater effect on weight in adolescents who are overweight. | Prospective cohort, association without proof of a cause27 |
| Cortisone over a longer period and at higher doses is more often associated with fat redistribution. | Observational studies with a dose relationship2324 |
| Support programmes can slow weight gain on antipsychotics. | Meta-analysis of 17 randomised trials29 |
| Gut bacteria may be involved in weight gain on olanzapine. | Animal study in rats, open question in humans9 |
Supported by large RCTs / meta-analyses:
Many medications can change your weight, most clearly some antipsychotics, insulin and sulfonylureas. Support programmes can slow weight gain on antipsychotics. On average, the pill does not show a large effect on weight.152529
Mechanistically plausible, human studies still thin:
The role of gut bacteria on olanzapine comes from experiments in rats. The idea that blocking the histamine receptor loosens the satiety brake is based on lab values for receptor binding that match the observed weight gain.79
Clinical tradition without a strong study base:
Noting your weight and waist circumference before starting a medication is established practice. There are hardly any studies that test exactly this step. But it only costs you a tape measure and two minutes.
From my clinical practice:
Clinically, I observe that people are more likely to stay with a good therapy when weight is discussed openly from the start. This is an experience from my practice, not a study.
Keeping an eye on your weight is not a luxury. It is freedom. The freedom to continue a good therapy and still feel at home in your body.
What this means in concrete terms: there are three levers you can take into your own hands from today.
Measure from day one
Note your weight and waist circumference before you start, or at the latest now. After that, once a week, always under the same conditions. That way you notice a change before your trousers tell you about it.
Bring your questions
Take the questions from this article with you to your next appointment. Together with your doctor, you can weigh up whether the dose, timing, form or drug could be adjusted.
Strengthen your foundation
Protein from legumes, eggs and dairy products can keep you full for a long time. Good sleep, daily exercise and strength training can strengthen your muscles as extra furnaces. You can read how to protect your muscles in a targeted way in the article Preserving muscle while losing weight.
The trousers that no longer close are not a verdict on you. They are a signal that you can take seriously and put into context together. In this way, an annoyance becomes a reason to talk.
And now you know why the wiser path does not lead through quietly leaving out your medication, but through measuring, asking and a strong foundation.
If you'd like to do more than read and get started right away: below this article you'll find the option to book an appointment.
Frequently asked questions about medication and weight
Which medications can lead to weight gain?
Commonly involved are some antidepressants such as mirtazapine, paroxetine and tricyclic drugs, antipsychotics such as olanzapine and clozapine, lithium, valproate, pregabalin and gabapentin. Added to these are cortisone, older beta blockers, insulin, sulfonylureas, glitazones, some antihistamines and the three-month contraceptive injection. How much your weight changes differs greatly from person to person.
How quickly does weight gain from medication appear?
That depends on the mechanism. Water retention, for example on cortisone or glitazones, can appear within days to weeks. Weight gain through more appetite or a reduced energy expenditure usually builds up over months. That is why it is worth measuring from day one.
Can I stop taking a medication if I gain weight?
Please don't do this on your own. Many medications need a planned exit, otherwise you may risk withdrawal symptoms, seizures, dangerous swings in blood sugar or a relapse. Instead, raise the weight gain early. Together with your doctor, you can check whether an adjustment or a switch is an option.
Does the pill make you gain weight?
For combined pills and patches, a Cochrane review of 49 randomised trials found no large effect on weight, but the data are not sufficient for a final verdict. With progestin-only methods, the mean gain in most studies was under two kilograms. The three-month injection deserves a look of its own, especially in adolescents who are overweight.
Does cortisone always make you gain weight?
No, not everyone gains weight on cortisone. The risk rises with dose and duration: more appetite, water retention and a shift of fat towards the belly, neck and face then become more common. Sprays, ointments or inhalers usually put considerably less strain on the metabolism than tablets.
Do all antidepressants make you gain weight?
No. The differences between the drugs are large. Mirtazapine, paroxetine and tricyclic drugs such as amitriptyline are more likely to stand out with weight gain, while other drugs behave more neutrally. Which option suits you also depends on your symptoms and belongs in a conversation with your doctor.
Can beta blockers change your weight?
Yes, especially older beta blockers such as metoprolol. In a systematic analysis, weight on beta blockers was on average slightly higher than in the comparison groups. In a randomised trial, carvedilol performed more favourably than metoprolol. One possible reason is a slightly reduced energy expenditure.
How can I tell whether it is water or fat?
Water often comes quickly, fluctuates from day to day and shows up in your ankles, fingers or eyelids. If a dent remains after you press your thumb into your shin, that points to water. Fat builds up more slowly and tends to show up in your waist circumference. Sudden swelling, shortness of breath or several kilograms more within a few days should be checked by a doctor promptly.
Are there weight-neutral alternatives?
For many drug groups, yes. A review from Toronto found alternatives in most of the groups studied that are considered weight-neutral or are even associated with weight loss. Whether a switch makes sense for you depends on your condition, your medical history and how well your current medication works for you.
What can I do myself without changing my medication?
Quite a lot. Measure your weight and waist from day one, eat protein from legumes, eggs and dairy products, get enough sleep and move every day, ideally with strength training too. With support programmes ranging from nutritional counselling to behavioural therapy, weight on antipsychotics was around three kilograms lower on average in studies.
How medication and weight are connected to other topics
Medication is rarely the only factor. Stress, sleep, blood sugar, your thyroid and your gut mesh like cogs. These articles show you the connections.
Cortisol and belly fat
How your body's own stress hormone, much like cortisone, can store fat on your belly.
When your blood sugar fluctuatesInsulin resistance and belly fat
Why the warehouse manager insulin can become sluggish and how you can counteract this.
When medication puts a strain on your gutYour gut after antibiotics and medication
What your gut may need after a phase of taking medication.
When your mood plays a partExercise for depression and anxiety
How exercise can support your mood alongside medical treatment.
When insulin is involvedStrength training for diabetes
Why your muscles, as extra furnaces, can ease the load on your blood sugar.
When your thyroid puts on the brakesThyroid and weight
Why an underactive thyroid can turn down your energy expenditure.
More from the weight loss guide
- Understanding weight holistically
- Losing belly fat
- Why am I not losing weight?
- Insulin resistance and belly fat
- Leptin and insulin
- Hunger and satiety
- Understanding cravings
- Cravings for sweets
- Emotional eating
- Sleep and weight loss
- The calorie myth
- Set point theory
- Avoiding the yo-yo effect
- Thyroid and weight
- Losing weight after pregnancy
- Apple cider vinegar and weight loss
- Weight-loss injection: what it can do
- Protecting your muscles on the weight-loss injection
- Stopping the weight-loss injection
- Cortisol and belly fat
- Preserving muscle while losing weight
- All articles in the weight loss guide
Scientific sources
30 sources, all checked via PubMed and linked with PMID and DOI. The figures in the text come from the study abstracts. Animal and laboratory studies are marked as such in the text. Research as of November 2026.
Overview and mechanisms
- Domecq JP, Prutsky G, Leppin A, et al. Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(2):363-370. PMID: 25590213 · DOI: 10.1210/jc.2014-3421 [Meta-analysis, 257 RCTs]
- Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342-362. PMID: 25590212 · DOI: 10.1210/jc.2014-3415 [Review, Endocrine Society guideline]
Appetite and the brain
- Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71(10):1259-1272. PMID: 21062615 · DOI: 10.4088/JCP.09r05346blu [Meta-analysis, 116 studies]
- Gafoor R, Booth HP, Gulliford MC. Antidepressant utilisation and incidence of weight gain during 10 years' follow-up: population based cohort study. BMJ. 2018;361:k1951. PMID: 29793997 · DOI: 10.1136/bmj.k1951 [Real-world, cohort, n = 294,719]
- Pillinger T, McCutcheon RA, Vano L, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(1):64-77. PMID: 31860457 · DOI: 10.1016/S2215-0366(19)30416-X [Meta-analysis, network, 100 RCTs]
- Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One. 2014;9(4):e94112. PMID: 24763306 · DOI: 10.1371/journal.pone.0094112 [Meta-analysis, 307 studies]
- Kroeze WK, Hufeisen SJ, Popadak BA, et al. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2003;28(3):519-526. PMID: 12629531 · DOI: 10.1038/sj.npp.1300027 [In vitro, receptor binding, 17 drugs]
- Ratliff JC, Barber JA, Palmese LB, Reutenauer EL, Tek C. Association of prescription H1 antihistamine use with obesity: results from the National Health and Nutrition Examination Survey. Obesity (Silver Spring). 2010;18(12):2398-2400. PMID: 20706200 · DOI: 10.1038/oby.2010.176 [Real-world, case-control analysis, NHANES]
- Davey KJ, Cotter PD, O'Sullivan O, Crispie F, Dinan TG, Cryan JF, O'Mahony SM. Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry. 2013;3(10):e309. PMID: 24084940 · DOI: 10.1038/tp.2013.83 [In vivo, rat]
Antiepileptics, lithium and nerve pain medication
- Verrotti A, D'Egidio C, Mohn A, Coppola G, Chiarelli F. Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications. Obes Rev. 2011;12(5):e32-e43. PMID: 20880119 · DOI: 10.1111/j.1467-789X.2010.00800.x [Systematic review]
- Gomes-da-Costa S, Marx W, Corponi F, et al. Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;134:104266. PMID: 34265322 · DOI: 10.1016/j.neubiorev.2021.07.011 [Meta-analysis, 9 studies]
- Cabrera J, Emir B, Dills D, Murphy TK, Whalen E, Clair A. Characterizing and understanding body weight patterns in patients treated with pregabalin. Curr Med Res Opin. 2012;28(6):1027-1037. PMID: 22494020 · DOI: 10.1185/03007995.2012.684044 [Meta-analysis, pooled study data, n = 3,187]
- Zaccara G, Gangemi P, Perucca P, Specchio L. The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials. Epilepsia. 2011;52(4):826-836. PMID: 21320112 · DOI: 10.1111/j.1528-1167.2010.02966.x [Meta-analysis, 38 RCTs]
- Onakpoya IJ, Thomas ET, Lee JJ, Goldacre B, Heneghan CJ. Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials. BMJ Open. 2019;9(1):e023600. PMID: 30670513 · DOI: 10.1136/bmjopen-2018-023600 [Meta-analysis, 28 RCTs]
Insulin and diabetes medication
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853. PMID: 9742976 · DOI: 10.1016/S0140-6736(98)07019-6 [RCT, n = 3,867]
- Phung OJ, Scholle JM, Talwar M, Coleman CI. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA. 2010;303(14):1410-1418. PMID: 20388897 · DOI: 10.1001/jama.2010.405 [Meta-analysis, 27 RCTs]
- Russell-Jones D, Khan R. Insulin-associated weight gain in diabetes: causes, effects and coping strategies. Diabetes Obes Metab. 2007;9(6):799-812. PMID: 17924864 · DOI: 10.1111/j.1463-1326.2006.00686.x [Review]
- Nesto RW, Bell D, Bonow RO, et al. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Circulation. 2003;108(23):2941-2948. PMID: 14662691 · DOI: 10.1161/01.CIR.0000103683.99399.7E [Review, consensus statement from the AHA and ADA]
Beta blockers and energy expenditure
- Sharma AM, Pischon T, Hardt S, Kunz I, Luft FC. Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. Hypertension. 2001;37(2):250-254. PMID: 11230280 · DOI: 10.1161/01.hyp.37.2.250 [Review, systematic analysis, 8 RCTs]
- Messerli FH, Bell DS, Fonseca V, et al. Body weight changes with beta-blocker use: results from GEMINI. Am J Med. 2007;120(7):610-615. PMID: 17602935 · DOI: 10.1016/j.amjmed.2006.10.017 [RCT, n = 1,106]
- Lee P, Kengne AP, Greenfield JR, Day RO, Chalmers J, Ho KK. Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic? Int J Obes (Lond). 2011;35(11):1395-1403. PMID: 21304487 · DOI: 10.1038/ijo.2010.284 [Real-world, cross-sectional analysis and mechanistic study, ADVANCE, n = 11,140]
Cortisone
- Berthon BS, MacDonald-Wicks LK, Wood LG. A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans. Nutr Res. 2014;34(3):179-190. PMID: 24655484 · DOI: 10.1016/j.nutres.2013.12.006 [Systematic review, 21 studies]
- Huscher D, Thiele K, Gromnica-Ihle E, Hein G, Demary W, Dreher R, Zink A, Buttgereit F. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis. 2009;68(7):1119-1124. PMID: 18684744 · DOI: 10.1136/ard.2008.092163 [Real-world, cross-sectional analysis, n = 1,066]
- Fardet L, Cabane J, Lebbé C, Morel P, Flahault A. Incidence and risk factors for corticosteroid-induced lipodystrophy: a prospective study. J Am Acad Dermatol. 2007;57(4):604-609. PMID: 17582650 · DOI: 10.1016/j.jaad.2007.04.018 [Real-world, prospective cohort, n = 88]
Hormonal contraception
- Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev. 2014;(1):CD003987. PMID: 24477630 · DOI: 10.1002/14651858.CD003987.pub5 [Systematic review, Cochrane, 49 RCTs]
- Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, Helmerhorst FM. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 2016;(8):CD008815. PMID: 27567593 · DOI: 10.1002/14651858.CD008815.pub4 [Systematic review, Cochrane, 22 studies, n = 11,450]
- Bonny AE, Ziegler J, Harvey R, Debanne SM, Secic M, Cromer BA. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med. 2006;160(1):40-45. PMID: 16389209 · DOI: 10.1001/archpedi.160.1.40 [Real-world, prospective cohort, n = 450]
Stopping, support and alternatives
- Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. Lancet Psychiatry. 2024;11(7):526-535. PMID: 38851198 · DOI: 10.1016/S2215-0366(24)00133-0 [Meta-analysis, 79 studies, n = 21,002]
- Caemmerer J, Correll CU, Maayan L. Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials. Schizophr Res. 2012;140(1-3):159-168. PMID: 22763424 · DOI: 10.1016/j.schres.2012.03.017 [Meta-analysis, 17 RCTs]
- Wharton S, Raiber L, Serodio KJ, Lee J, Christensen RA. Medications that cause weight gain and alternatives in Canada: a narrative review. Diabetes Metab Syndr Obes. 2018;11:427-438. PMID: 30174450 · DOI: 10.2147/DMSO.S171365 [Review, narrative]
The data on gut flora under olanzapine come from experiments in rats. The receptor data on the satiety brake come from laboratory experiments. They show possible pathways, not established processes in humans.
Observational studies (antidepressants in everyday life, antihistamines, beta blockers and energy expenditure, cortisone, the three-month injection in adolescents) show associations, but not causes. The Cochrane reviews on contraception rate the evidence as limited.
The scene at the beginning is an invented example and does not describe a real person. This article is for information purposes and does not replace a medical examination.